These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 8618285)

  • 21. [Systemic therapy of muscle invasive bladder cancer - an update].
    Niedersüss-Beke D
    Wien Med Wochenschr; 2011 Aug; 161(15-16):371-3. PubMed ID: 21953426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoadjuvant chemotherapy in deeply invasive bladder cancer: the Italian experience. The Lombard Urologists.
    Semin Urol; 1990 Aug; 8(3):205-9. PubMed ID: 2204982
    [No Abstract]   [Full Text] [Related]  

  • 23. Combined radiotherapy, chemotherapy and surgery in the management of invasive bladder cancer.
    Jakse G; Frommhold H
    Prog Clin Biol Res; 1988; 269():591-600. PubMed ID: 3393556
    [No Abstract]   [Full Text] [Related]  

  • 24. [Standards and perspectives in diagnosis and therapy of bladder carcinoma].
    Stief C; Zaak D; Stöckle M; Studer U; Knuechel R; Rödel C; Sauer R; Rubben H
    Urologe A; 2006 Sep; 45 Suppl 4():90-6. PubMed ID: 16896761
    [No Abstract]   [Full Text] [Related]  

  • 25. Superficial TCC bladder cancer: the impact of tumor differentiation on recurrence, progression and survival.
    Kurth KH
    Prog Clin Biol Res; 1984; 162A():307-18. PubMed ID: 6483914
    [No Abstract]   [Full Text] [Related]  

  • 26. Point and counterpoint. Radical cystectomy or multimodality therapy for TCC of the bladder?
    Zietman AL; Shipley WU; Kaufman DS; Esrig D; Lytton B
    Contemp Urol; 1995 Jul; 7(7):23-4, 29, 32, passim. PubMed ID: 10150577
    [No Abstract]   [Full Text] [Related]  

  • 27. Locally advanced bladder cancer. Radiation therapy and chemotherapy.
    Gospodarowicz MK
    Eur Urol; 1998; 33 Suppl 4():27-31. PubMed ID: 9615207
    [No Abstract]   [Full Text] [Related]  

  • 28. T1G3 bladder cancer--the case for TUR and BCG.
    Miller K
    Front Radiat Ther Oncol; 2002; 36():147-50. PubMed ID: 11842744
    [No Abstract]   [Full Text] [Related]  

  • 29. The optimal management of T1G3 bladder cancer.
    Emiliozzi P; Pansadoro A; Pansadoro V
    BJU Int; 2008 Nov; 102(9 Pt B):1265-73. PubMed ID: 19035891
    [No Abstract]   [Full Text] [Related]  

  • 30. [Conservative treatment of bladder cancers with radiotherapy and concurrent chemotherapy: results and perspectives].
    Chauvet B; Davin JL; Alfonsi M; Berger C; Vincent P; Reboul F
    Cancer Radiother; 1998; 2(5):499-504. PubMed ID: 9868392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation criteria: a protocol to study patterns of care and their effects in patients with transitional cell carcinoma of the bladder (protocol 1).
    Prout GR; Kopp J
    Prog Clin Biol Res; 1984; 162A():285-99. PubMed ID: 6483913
    [No Abstract]   [Full Text] [Related]  

  • 32. An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma.
    Tsukamoto S; Ishikawa S; Tsutsumi M; Nakajima K; Sugahara S
    Scand J Urol Nephrol; 2002; 36(5):339-43. PubMed ID: 12487737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Conservative treatment with chemotherapy and radiotherapy in bladder cancer invading the muscle: preliminary results of a prospective study].
    Zapatero A; Pinar B; Arellano R; López M; Marín A; Jiménez U; Pérez Torrubia A
    Arch Esp Urol; 1997 Jun; 50(5):448-54; discussion 454-6. PubMed ID: 9382586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retrospective analysis of the efficacy of two cycles of M-VAC neoadjuvant chemotherapy followed by radical cystectomy for muscle-invasive bladder cancer.
    Kitagawa Y; Izumi K; Miwa S; Kadono Y; Konaka H; Mizokami A; Namiki M
    Anticancer Res; 2013 Oct; 33(10):4497-503. PubMed ID: 24123021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of high-risk, non-muscle-invasive bladder cancer.
    Lerner SP
    Nat Clin Pract Urol; 2006 Aug; 3(8):398-9. PubMed ID: 16902498
    [No Abstract]   [Full Text] [Related]  

  • 36. Adjuvant chemotherapy of bladder cancer.
    Freiha FS; Torti FM
    Prog Clin Biol Res; 1988; 260():545-9. PubMed ID: 3129738
    [No Abstract]   [Full Text] [Related]  

  • 37. Trimodality therapy for bladder conservation in treatment of invasive bladder cancer.
    Mitin T; Shipley WU; Efstathiou JA; Heney NM; Kaufman DS; Lee RJ; Zietman AL
    Curr Urol Rep; 2013 Apr; 14(2):109-15. PubMed ID: 23341373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update.
    Hall MC; Chang SS; Dalbagni G; Pruthi RS; Seigne JD; Skinner EC; Wolf JS; Schellhammer PF
    J Urol; 2007 Dec; 178(6):2314-30. PubMed ID: 17993339
    [No Abstract]   [Full Text] [Related]  

  • 40. Bladder cancer: improving care with better classification and risk stratification.
    Lamm D
    J Urol; 2007 Oct; 178(4 Pt 1):1146-7. PubMed ID: 17698132
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.